FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The Global Prefilled Auto Injectors Market is projected to grow at a CAGR of 8.4% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market ...

An updated edition of the December 16, 2025, article. An aging U.S. population is becoming a first-order driver of consumption reallocation. Going by the data from the United States Census Bureau, by ...

The loveliest skin, health and wellbeing destinations, all in one place ...

The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

California’s governor has been touted as the Democrats’ best shot in 2028. But first he’ll need to convince voters that he’s not just a slick establishment politician.

A groundbreaking new study offers hope that people with diabetes may no longer need to take insulin injections every day. The research, published in Science Translational Medicine, was led by ...

Over the past decade, the use of artificial intelligence (AI) has radically transformed the understanding and clinical approach to diabetes. Advances such ...

Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter ...

GLP-1 Drugs: New Questions on Mental Health and Sarcopenia GLP-1 receptor agonists show promise beyond obesity but require careful use due to sarcopenia risk and complex effects on mental health.

Insulet plans to introduce Omnipod Discover in its Middle Eastern markets first, then expand to other countries where Omnipod ...